TGF-β increases cholesterol efflux and ABC-1 expression in macrophage-derived foam cells: Opposing the effects of IFN-γ

Journal of Lipid Research

Volumn 42, Issue 5, 2001, Pages 856-863

  Panousis, Constantinos G ^a,b   Evans, Glenn ^a   Zuckerman, Steven H ^a  

^a ELI LILLY AND COMPANY   (United States)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

ApoA I; Cytokines; Inflammation; Reverse cholesterol transport

Indexed keywords

ABC TRANSPORTER; APOLIPOPROTEIN E; BETA CYCLODEXTRIN; CHOLESTEROL ESTER; CYTOKINE; GAMMA INTERFERON; MACROPHAGE ACTIVATING FACTOR; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROMA; ATHEROSCLEROSIS; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; DOWN REGULATION; KNOCKOUT MOUSE; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ANIMALS; APOLIPOPROTEINS E; ATP-BINDING CASSETTE TRANSPORTERS; BETA-CYCLODEXTRINS; CELLS, CULTURED; CHOLESTEROL; CYCLODEXTRINS; DOSE-RESPONSE RELATIONSHIP, DRUG; FOAM CELLS; IMMUNOBLOTTING; INTERFERON TYPE II; LIPOPROTEINS, HDL; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; TRANSFORMING GROWTH FACTOR BETA;

EID: 0034986470     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Molecular mechanisms of reverse cholesterol transport
2. Mechanisms of high density lipoprotein-mediated efflux of cholesterol from cell plasma membranes
3. An overview of reverse cholesterol transport
4. Regulation of cholesterol distribution in macrophage-derived foam cells by gamma interferon (IFN-γ)
5. Reduction of cholesterol efflux to free apolipoprotein AI by interferon gamma is associated with the down regulation of the expression of the Tangier's disease gene ABC1
6. IFN-gamma potentiates atherosclerosis in ApoE knock-out mice
7. Regulation of apolipoprotein E expression in macrophages by γ-interferon
8. Expression of class II transplantation antigen on vascular smooth muscle cells in human atherosclerosis
9. Identification of interferon-γ as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity
10. Interferon-γ inhibits scavenger receptor expression and foam cell formation in human monocyte-derived macrophages
11. 2
12. Down regulation of macrophage CD36 expression and HDL binding by TGF-β
13. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease
14. Tranforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor
15. Macrophage deactivating factor and transforming factor-β1 -β2, and -β3 inhibit induction of macrophage nitric oxide synthesis by IFN-γ
16. Transforming growth factor β1 induces IL-1 receptor antagonist production and gene expression in rat vascular smooth muscle cells
17. Cytokine regulation of macrophage apoE secretion: Opposing effects of GM-CSF and TGF-β
18. Transforming growth factor-beta 1 inhibits scavenger receptor activity in THP-1 human macrophages
19. Production of transforming growth factor β1 during repair of arterial injury
20. Antibodies against transforming growth factor β1 suppress intimal hyperplasia in a rat model
21. The serum concentration of active transforming growth factor-β is severely depressed in advanced atherosclerosis
22. Systemic inflammatory parameters in patients with atherosclerosis of the coronary and peripheral arteries
23. Distinct patterns of transforming growth factor-β isoform and receptor expression in human atherosclerotic lesions. Colocalization implicates TGF-β in fibrofatty lesion development
24. Circulating transforming growth factor β and coronary artery disease
25. Expression of transforming growth factor-β1 is increased in human vascular restenosis lesions
26. Tamoxifen decreases cholesterol sevenfold and abolishes lipid lesion development in apolipoprotein E knockout mice
27. Both early, and delayed anti-CD40L antibody treatment induces a stable plaque phenotype
28. Apolipoprotein-mediated removal of cellular cholesterol and phospholipids
29. Cholesterol efflux mediated by apolipoproteins is an active process distinct from efflux mediated by passive diffusion
30. Apolipoproteins, membrane cholesterol domains, and the regulation of cholesterol efflux
31. Scavenger receptor BI (SR-BI) mediates free cholesterol flux independently of HDL tethering to the cell surface
32. Cyclodextrins as catalysts for the removal of cholesterol from macrophage foam cells
33. Molecular cloning of the human ATP-binding cassette transporter 1 (hABC1): Evidence for sterol-dependent regulation in macrophages
34. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease
35. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1
36. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency
37. A pivotal role for TGF-β in atherogenesis?
38. The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway
39. Decreased reverse cholesterol transport from Tangier disease fibroblasts. Acceptor specificity, and effect of brefeldin on lipid efflux
40. Scavenger receptor-BI (SR-BI) inhibits ATP binding cassette transporter 1 (ABC1)-mediated cholesterol efflux in macrophages
41. Transforming growth factor-β inhibits human T cell proliferation through multiple targets
42. Deactivation of macrophages by transforming growth factor-β
43. Regulation of Trypanosoma cruzi infections in vivo by transforming growth factor β (TGF-β)
44. Regulation by transforming factor-β1 of expression and function of the receptor for IFN-γ on mouse macrophages
45. TGF-β suppression of IFN-γ-induced class II MHC gene expression does not involve inhibition of phosphorylation of JAK1, JAK2, or signal transducers and activators of transcription, or modification of IFN-γ enhanced factor X expression
46. Inhibition of transforming growth factor-β/SMAD signaling by the interferon-γ/STAT pathway
47. Cyclic AMP stimulates efflux of intracellular sterol from cholesterol-loaded cells
48. The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway
49. Sterol dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor
50. Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers